Ken Kasper
Biographic Data
| ID | 8932054 |
|---|---|
| NAME | Ken Kasper |
| GIVEN NAMES | Ken |
| FAMILY NAME | Kasper |
| SIGNATURE | KASPER K |
| AFFILIATIONS | University of Manitoba |
| VERIFIED | No |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2015 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Trauma, empowerment, and resilience
Introduction: Canada has endorsed the Joint United Nations Programme on HIV/AIDS (UNAIDS) target to end the HIV epidemic by 2030. However, Canada has reported increases in HIV diagnoses for five consecutive years since 2019, with Manitoba's provincial rates three times the national average. This study examines mental health factors that may impact engagement in care among people living with HIV in Manitoba. Methods: For this qualitative study, 32…
Service providers’ perspectives on facilitators and recommendations for improving HIV care in Manitoba, Canada
Background: We aimed to identify facilitators and recommendations for improving HIV care in Manitoba, Canada from service providers' perspectives. Methods: This study is a component of a participatory action research study examining the interrelatedness of houselessness, substance use and other factors on HIV care. We conducted in-depth, semi-structured interviews with 27 HIV service providers in Manitoba (Canada). Interviews were transcribed, co…
Barriers and recommendations for harm reduction services among people living with HIV in Manitoba, Canada
Introduction: In 2022, the province of Manitoba, Canada, recorded its highest increases in substance-related deaths and new HIV diagnoses. The COVID-19 pandemic exacerbated access barriers to harm reduction services across the country. Given the intertwined relationship between HIV and injection substance use, we sought to better understand People Living with HIV's (PLHIV) access barriers to harm reduction services, and recommendations for improv…
Prior history of testing for syphilis, hepatitis B and hepatitis C among a population-based cohort of HIV-positive individuals and their HIV-negative controls
Understanding patterns of serological testing for hepatitis B & C, and syphilis among HIV-positive individuals, prior to HIV diagnosis, can inform HIV diagnosis, engagement and prevention strategies. This was a population-based, retrospective analysis of prior serological testing among HIV-positive individuals in Manitoba, Canada. HIV cases were age-, sex- and region-matched to HIV-negative controls at a 1:5 ratio. Conditional logistic regression…
Substance use and its impact on care outcomes among HIV-infected individuals in Manitoba
The high prevalence of substance use among HIV-infected individuals creates numerous challenges to patient care. This study was undertaken in order to understand the impact of substance use on care outcomes for HIV-infected individuals in Manitoba. Clinical records of 564 HIV-infected individuals in care at Health Sciences Centre in Winnipeg, Manitoba were reviewed. Clinical data were extracted from patient charts for substance users (illicit sub…
No prominent works on this page.
Substance use and its impact on care outcomes among HIV-infected individuals in Manitoba
The high prevalence of substance use among HIV-infected individuals creates numerous challenges to patient care. This study was undertaken in order to understand the impact of substance use on care outcomes for HIV-infected individuals in Manitoba. Clinical records of 564 HIV-infected individuals in care at Health Sciences Centre in Winnipeg, Manitoba were reviewed. Clinical data were extracted from patient charts for substance users (illicit sub…
Prior history of testing for syphilis, hepatitis B and hepatitis C among a population-based cohort of HIV-positive individuals and their HIV-negative controls
Understanding patterns of serological testing for hepatitis B & C, and syphilis among HIV-positive individuals, prior to HIV diagnosis, can inform HIV diagnosis, engagement and prevention strategies. This was a population-based, retrospective analysis of prior serological testing among HIV-positive individuals in Manitoba, Canada. HIV cases were age-, sex- and region-matched to HIV-negative controls at a 1:5 ratio. Conditional logistic regression…
Service providers’ perspectives on facilitators and recommendations for improving HIV care in Manitoba, Canada
Background: We aimed to identify facilitators and recommendations for improving HIV care in Manitoba, Canada from service providers' perspectives. Methods: This study is a component of a participatory action research study examining the interrelatedness of houselessness, substance use and other factors on HIV care. We conducted in-depth, semi-structured interviews with 27 HIV service providers in Manitoba (Canada). Interviews were transcribed, co…
Barriers and recommendations for harm reduction services among people living with HIV in Manitoba, Canada
Introduction: In 2022, the province of Manitoba, Canada, recorded its highest increases in substance-related deaths and new HIV diagnoses. The COVID-19 pandemic exacerbated access barriers to harm reduction services across the country. Given the intertwined relationship between HIV and injection substance use, we sought to better understand People Living with HIV's (PLHIV) access barriers to harm reduction services, and recommendations for improv…
Trauma, empowerment, and resilience
Introduction: Canada has endorsed the Joint United Nations Programme on HIV/AIDS (UNAIDS) target to end the HIV epidemic by 2030. However, Canada has reported increases in HIV diagnoses for five consecutive years since 2019, with Manitoba's provincial rates three times the national average. This study examines mental health factors that may impact engagement in care among people living with HIV in Manitoba. Methods: For this qualitative study, 32…
HIV/AIDS Research and Interventions (5 works) · HIV, Drug Use, Sexual Risk (4 works) · Medicine (3 works) · Demography (2 works) · Family medicine (2 works) · Homelessness and Social Issues (2 works) · Logistic regression (2 works) · Antibody (1 works) · Business (1 works) · Cohort (1 works)